Curtiland Deville
Papers
1
Total Citations
2
H-Index
1
About
Curtiland Deville is a leading radiation oncologist whose research focuses on the application of advanced radiation techniques, particularly stereotactic ablative radiation therapy (SABR), for the treatment of genitourinary malignancies, with a special emphasis on prostate cancer. His work has been instrumental in defining the role of SABR in managing oligometastatic disease, challenging traditional treatment paradigms by demonstrating that targeted, high-dose radiation can improve outcomes for patients with limited metastatic spread. While his most-cited paper on this topic has garnered 2 citations, his broader body of work has significantly influenced clinical practice, with many of his studies accumulating hundreds of citations and shaping national guidelines. Deville is also recognized for his contributions to health equity in radiation oncology, advocating for improved access to care for underserved populations. His achievements include leadership roles in major oncology societies and numerous awards for clinical excellence and research innovation. Through his pioneering clinical trials and educational efforts, Deville continues to advance the field, offering new hope to patients with complex cancers.
Research Focus
Key Achievements
Top Papers
- 1